Penserra Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $225K | Buy |
1,760
+7
| +0.4% | +$819 | ﹤0.01% | 684 |
|
|
2026
Q1 | $209K | Sell |
1,753
-9,218
| -84% | -$1.06M | ﹤0.01% | 664 |
|
|
2025
Q4 | $1.15M | Buy |
10,971
+9,000
| +457% | +$845K | 0.01% | 411 |
|
|
2025
Q3 | $164K | Buy |
1,971
+105
| +6% | +$8.65K | ﹤0.01% | 725 |
|
|
2025
Q2 | $147K | Sell |
1,866
-355
| -16% | -$28.2K | ﹤0.01% | 681 |
|
|
2025
Q1 | $198K | Sell |
2,221
-6,314
| -74% | -$590K | ﹤0.01% | 739 |
|
|
2024
Q4 | $848K | Buy |
8,535
+6,344
| +290% | +$654K | 0.02% | 450 |
|
|
2024
Q3 | $248K | Sell |
2,191
-1,012,227
| -100% | -$120M | 0.01% | 673 |
|
|
2024
Q2 | $126M | Buy |
1,014,418
+228,418
| +29% | +$29.4M | 1.59% | 13 |
|
|
2024
Q1 | $104M | Sell |
786,000
-87,295
| -10% | -$10.8M | 1.3% | 19 |
|
|
2023
Q4 | $95.2M | Sell |
873,295
-218,074
| -20% | -$22.6M | 1.79% | 16 |
|
|
2023
Q3 | $112M | Sell |
1,091,369
-144,292
| -12% | -$15.6M | 2.32% | 14 |
|
|
2023
Q2 | $143M | Buy |
1,235,661
+468,262
| +61% | +$53.2M | 2.82% | 10 |
|
|
2023
Q1 | $81.6M | Sell |
767,399
-460,813
| -38% | -$49.8M | 1.69% | 18 |
|
|
2022
Q4 | $136M | Buy |
1,228,212
+238,981
| +24% | +$24.4M | 2.99% | 2 |
|
|
2022
Q3 | $85.2M | Buy |
989,231
+291,569
| +42% | +$26M | 2.42% | 8 |
|
|
2022
Q2 | $63.6M | Buy |
697,662
+381,079
| +120% | +$33.8M | 1.73% | 12 |
|
|
2022
Q1 | $26M | Buy |
+316,583
| New | +$25M | 0.62% | 38 |
|
|
2020
Q4 | – | Sell |
-40,309
| Closed | -$3.19M | – | 1094 |
|
|
2020
Q3 | $3.19M | Buy |
40,309
+23,686
| +142% | +$1.86M | 0.12% | 167 |
|
|
2020
Q2 | $1.23M | Sell |
16,623
-1,939
| -10% | -$146K | 0.06% | 227 |
|
|
2020
Q1 | $1.36M | Sell |
18,562
-17,422
| -48% | -$1.37M | 0.09% | 208 |
|
|
2019
Q4 | $3.12M | Buy |
35,984
+11,973
| +50% | +$983K | 0.2% | 139 |
|
|
2019
Q3 | $1.93M | Sell |
24,011
-4,740
| -16% | -$380K | 0.16% | 117 |
|
|
2019
Q2 | $2.3M | Buy |
28,751
+1,371
| +5% | +$105K | 0.18% | 104 |
|
|
2019
Q1 | $2.06M | Buy |
27,380
+8,973
| +49% | +$671K | 0.16% | 104 |
|
|
2018
Q4 | $1.34M | Buy |
+18,407
| New | +$1.3M | 0.13% | 167 |
|
|
2017
Q3 | – | Sell |
-7,635
| Closed | -$466K | – | 576 |
|
|
2017
Q2 | $466K | Buy |
7,635
+3,799
| +99% | +$231K | 0.17% | 101 |
|
|
2017
Q1 | $232K | Buy |
3,836
+2,557
| +200% | +$155K | 0.02% | 172 |
|
|
2016
Q4 | $71K | Buy |
+1,279
| New | +$74.9K | 0.01% | 362 |
|
Other funds holding MRK
Penserra Capital Management's MRK Position: Q2 2026 in Review
Penserra Capital Management increased its Merck (MRK) stake by 0.4% in Q2 2026, buying an estimated $819 and bringing the position to 1,760 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #684.
Penserra Capital Management first reported a position in MRK in Q4 2016 and has held it in 29 quarters since. The position peaked at $143M in Q2 2023. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Penserra Capital Management held 1,760 shares of Merck worth $225K as of Q2 2026.
- Penserra Capital Management bought 7 Merck shares in Q2 2026, an estimated $819.
- Merck made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #684 holding.
- Penserra Capital Management first reported a position in Merck in Q4 2016 and has held it in 29 quarters since.
- Penserra Capital Management's Merck position peaked at $143M in Q2 2023.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.